FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007023975> ?p ?o ?g. }

• W2007023975 endingPage "1234" @default.
• W2007023975 startingPage "1227" @default.
• W2007023975 abstract "The aim of this study was to assess the 12-month efficacy of intravitreal bevacizumab (IVB) injection for occult choroidal neovascularization secondary to age-related macular degeneration.In this retrospective, interventional case series, 68 treatment-naïve patients with age-related macular degeneration, affected by subfoveal occult choroidal neovascularization showing recent disease progression, were monitored during the IVB protocol. The patients received 1 initial IVB injection (1.25 mg/0.05 mL), and they underwent further retreatment on a monthly basis only when necessary, according to a standardized as-required regimen, until no significant signs of choroidal neovascularization activity were present. Main outcome measures were the modifications in best-corrected visual acuity and in central retinal thickness measured by optical coherence tomography.With respect to baseline, at the 12-month check, mean best-corrected visual acuity increased from 0.82 to 0.45 logMAR (P < 0.01) and mean central retinal thickness decreased from 517.0 microm to 306.5 microm (P < 0.01). To achieve these benefits, the required mean IVB number was lowered from 3.87 in the first 6 months to 1.085 in the second 6 months. A better final best-corrected visual acuity was correlated with greater best-corrected visual acuity (P < 0.005) and lesser central retinal thickness (P < 0.05) at baseline.In patients with age-related macular degeneration complicated by progressive occult choroidal neovascularization, first-line IVB administration represents a useful therapeutic option, especially considering its lower cost in comparison with other antiangiogenic drugs." @default.
• W2007023975 created "2016-06-24" @default.
• W2007023975 creator A5001604979 @default.
• W2007023975 creator A5023102332 @default.
• W2007023975 creator A5026288161 @default.
• W2007023975 creator A5039083280 @default.
• W2007023975 creator A5045625180 @default.
• W2007023975 creator A5051685444 @default.
• W2007023975 creator A5073312340 @default.
• W2007023975 creator A5087619447 @default.
• W2007023975 date "2009-10-01" @default.
• W2007023975 modified "2023-10-16" @default.
• W2007023975 title "INTRAVITREAL BEVACIZUMAB FOR TREATMENT-NAÏVE PATIENTS WITH SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION" @default.
• W2007023975 cites W1519438798 @default.
• W2007023975 cites W1967821317 @default.
• W2007023975 cites W1968609549 @default.
• W2007023975 cites W1988233478 @default.
• W2007023975 cites W1990444805 @default.
• W2007023975 cites W1992257311 @default.
• W2007023975 cites W1993244458 @default.
• W2007023975 cites W200886222 @default.
• W2007023975 cites W2020050260 @default.
• W2007023975 cites W2021120588 @default.
• W2007023975 cites W2021415488 @default.
• W2007023975 cites W2021496037 @default.
• W2007023975 cites W2023523208 @default.
• W2007023975 cites W2029119558 @default.
• W2007023975 cites W2033245558 @default.
• W2007023975 cites W2041456566 @default.
• W2007023975 cites W2059505779 @default.
• W2007023975 cites W2065425407 @default.
• W2007023975 cites W2067016538 @default.
• W2007023975 cites W2069110097 @default.
• W2007023975 cites W207576288 @default.
• W2007023975 cites W2088432960 @default.
• W2007023975 cites W2090658196 @default.
• W2007023975 cites W2096735172 @default.
• W2007023975 cites W2107057433 @default.
• W2007023975 cites W2121103822 @default.
• W2007023975 cites W2123617249 @default.
• W2007023975 cites W2124415048 @default.
• W2007023975 cites W2131109619 @default.
• W2007023975 cites W2138630406 @default.
• W2007023975 cites W2233259956 @default.
• W2007023975 cites W3199981447 @default.
• W2007023975 cites W945208301 @default.
• W2007023975 doi "https://doi.org/10.1097/iae.0b013e3181b773e1" @default.
• W2007023975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19934817" @default.
• W2007023975 hasPublicationYear "2009" @default.
• W2007023975 type Work @default.
• W2007023975 sameAs 2007023975 @default.
• W2007023975 citedByCount "12" @default.
• W2007023975 countsByYear W20070239752013 @default.
• W2007023975 countsByYear W20070239752014 @default.
• W2007023975 countsByYear W20070239752016 @default.
• W2007023975 countsByYear W20070239752020 @default.
• W2007023975 crossrefType "journal-article" @default.
• W2007023975 hasAuthorship W2007023975A5001604979 @default.
• W2007023975 hasAuthorship W2007023975A5023102332 @default.
• W2007023975 hasAuthorship W2007023975A5026288161 @default.
• W2007023975 hasAuthorship W2007023975A5039083280 @default.
• W2007023975 hasAuthorship W2007023975A5045625180 @default.
• W2007023975 hasAuthorship W2007023975A5051685444 @default.
• W2007023975 hasAuthorship W2007023975A5073312340 @default.
• W2007023975 hasAuthorship W2007023975A5087619447 @default.
• W2007023975 hasConcept C118487528 @default.
• W2007023975 hasConcept C126322002 @default.
• W2007023975 hasConcept C141071460 @default.
• W2007023975 hasConcept C142724271 @default.
• W2007023975 hasConcept C204787440 @default.
• W2007023975 hasConcept C2776403814 @default.
• W2007023975 hasConcept C2776694085 @default.
• W2007023975 hasConcept C2777802072 @default.
• W2007023975 hasConcept C2778257484 @default.
• W2007023975 hasConcept C2778271429 @default.
• W2007023975 hasConcept C2780394083 @default.
• W2007023975 hasConcept C2780827179 @default.
• W2007023975 hasConcept C2781359195 @default.
• W2007023975 hasConcept C520017518 @default.
• W2007023975 hasConcept C71924100 @default.
• W2007023975 hasConceptScore W2007023975C118487528 @default.
• W2007023975 hasConceptScore W2007023975C126322002 @default.
• W2007023975 hasConceptScore W2007023975C141071460 @default.
• W2007023975 hasConceptScore W2007023975C142724271 @default.
• W2007023975 hasConceptScore W2007023975C204787440 @default.
• W2007023975 hasConceptScore W2007023975C2776403814 @default.
• W2007023975 hasConceptScore W2007023975C2776694085 @default.
• W2007023975 hasConceptScore W2007023975C2777802072 @default.
• W2007023975 hasConceptScore W2007023975C2778257484 @default.
• W2007023975 hasConceptScore W2007023975C2778271429 @default.
• W2007023975 hasConceptScore W2007023975C2780394083 @default.
• W2007023975 hasConceptScore W2007023975C2780827179 @default.
• W2007023975 hasConceptScore W2007023975C2781359195 @default.
• W2007023975 hasConceptScore W2007023975C520017518 @default.
• W2007023975 hasConceptScore W2007023975C71924100 @default.
• W2007023975 hasIssue "9" @default.
• W2007023975 hasLocation W20070239751 @default.
• W2007023975 hasLocation W20070239752 @default.

• next